For mouse B16-F10 melanoma cells, two independent clones targeted by different nucleotide sequences (designated as ARMS–RNAi-1 and ARMS–RNAi-2) had ARMS expression to the level around 40 and 20% of that in control, respectively (Figure 3C). This evidence concerns the gene KIDINS220 and melanoma.